Immune response to fowl cholera antigens.
Experimentally prepared and commercially manufactured bacterins were evaluated by a 2-stage bird protection bioassay. Ninety percent of the commercial bacterins gave acceptable protection levels to Pasteurella multocida type 1. Sixty-seven percent of the commercial bacterins produced acceptable protection to P. multocida type 3. Survival of 75 percent was considered acceptable protection.
D000818:Animals; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines / Q000008:administration & dosage; D002645:Chickens; D003470:Culture Media; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D010325:Pasteurella / Q000254:growth & development / Q000276:immunology*; D010326:Pasteurella Infections / Q000276:immunology / Q000401:mortality / Q000662:veterinary*; D011201:Poultry Diseases / Q000276:immunology* / Q000401:mortality; D014422:Turkeys; D014611:Vaccination / Q000662:veterinary
D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D003470:Culture Media